Institutional investors purchased a net $5.2 million shares of IONS during the quarter ended June 2016 and now own 91.77% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 90.0 Thousand shares of Ionis Pharmaceuticals Inc
DANSKE BANK A/S (INVT MGMT) Bought 53.7 Thousand shares of Ionis Pharmaceuticals Inc